List of insiders holdings for CG Oncology Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Song Hong Fang Unique Diamond Investments Ltd Charming Jade Ltd ORI Healthcare Fund L.P. ORI Healthcare Fund II L.P. ORI Capital Inc. ORI Capital II Inc. ORI Capital Holding Inc. Healthcare Seed Ltd Director 10% Owner | 2024-07-22 16:35:57 | 5,555,296 0 | 5,555,296 | Form 13G |
Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 2024-04-09 19:12:20 | 5,458,810 0 | 5,458,810 | Form 13G |
Song Hong Fang Director | 2024-12-17 18:03:16 | 613,928 3,590,913 | 4,204,841 | Form 4 |
Kuan Arthur Chief Executive Officer | 2024-10-07 16:51:28 | 397,800 0 | 397,800 | Form 4 |
Bellete Ambaw President and COO | 2024-10-07 17:00:19 | 175,500 0 | 175,500 | Form 4 |
POST LEONARD E Director | 2024-12-17 17:00:11 | 133,077 0 | 133,077 | Form 4 |
Kasturi Vijay Chief Medical Officer | 2024-10-07 17:07:01 | 132,600 0 | 132,600 | Form 4 |
Roche Corleen M. CFO | 2024-10-08 09:29:44 | 93,600 0 | 93,600 | Form 4 |
Patterson Joshua F. See Remarks | 2024-10-07 16:56:24 | 47,775 0 | 47,775 | Form 4 |
Mulay James Director | 2024-10-07 17:00:44 | 15,600 0 | 15,600 | Form 4 |
Tong Victor Edward Jr Director | 2024-10-07 17:07:42 | 15,600 0 | 15,600 | Form 4 |
Liu Brian Guan-Chyun Director | 2024-10-07 17:08:18 | 15,600 0 | 15,600 | Form 4 |
Graf Susan E Director | 2024-10-07 17:09:55 | 15,600 0 | 15,600 | Form 4 |